Related Experiment Video
Updated: Jul 12, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Automated reticulocyte counting: advances, standardization challenges, and clinical accessibility
Hongyin Zhou1, Yaxin Huang2, Ruijian Zhuang3
1Department of Clinical Laboratory, Zigong First People's Hospital, Zigong City, Sichuan Province, China.
Automated reticulocyte counting offers improved anemia diagnosis, but platform variations hinder comparability. Standardization efforts and accessible technologies are key for global clinical use.
Area of Science:
- Hematology
- Clinical Pathology
- Medical Technology
Background:
- Automated reticulocyte enumeration using flow cytometry has largely replaced manual microscopy since the 1980s.
- Key metrics like immature reticulocyte fraction (IRF) and reticulocyte production index (RPI) enhance anemia phenotyping and erythropoiesis tracking.
- Existing platforms exhibit heterogeneity in analytical principles, reagents, and calibration, limiting result comparability.
Purpose of the Study:
- To review the standardization and clinical accessibility of automated reticulocyte counting.
- To elaborate on the technical principles of mainstream automated reticulocyte counters.
- To analyze the challenges and advances in standardization and envision future applications.
Main Methods:
- Narrative review of automated reticulocyte counting technologies and standardization efforts.
- Systematic elaboration of core technical principles and characteristics of mainstream instruments.
- Analysis of advances and challenges in standardization and clinical accessibility.
Main Results:
- Automated reticulocyte counting significantly improves throughput, precision, and diagnostic resolution for anemias.
- Heterogeneity across platforms impedes consistent interpretation of results.
- The International Council for Standardization in Haematology (ICSH) is developing reference materials and harmonized intervals for interoperability.
Conclusions:
- Standardization initiatives are crucial for achieving comparable and uniformly interpretable reticulocyte count results globally.
- High costs and maintenance of advanced analyzers limit access to automated reticulocyte testing in many clinical settings.
- Future prospects involve overcoming standardization challenges and improving accessibility for widespread clinical application.
More Related Videos
14:14Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
05:52Author Spotlight: Efficient Retinal Ganglion Cell Counting in Mouse Models of Glaucoma for Treatment Evaluation
Published on: October 4, 2024